December 5, 2020
Business News

Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio

LONDON–()–The liquid biopsy market is poised to grow by USD 4.02 billion during 2020-2024, progressing at a CAGR of almost 38% during the forecast period.

The report on the liquid biopsy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing funding for liquid biopsy.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis


Click here to view the original article.

Related Posts

You might also like ...

post featured image
Kia recalling 295,000 vehicles due to risk of engine fires – Fox Business
AON Splash Image
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
New Data for TecartusTM Demonstrate Durable Responses at One Year Follow-Up in Relapsed or Refractory Mantle Cell Lymphoma